Dragonfly Research, LLC
1 clinical trials · Sponsor
◉ Watch Dragonfly Research, LLC
| Record | Firm | Date |
|---|---|---|
| Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab (NCT04837651) | Dragonfly Research, LLC | 2021-03-02 |
Track Dragonfly Research, LLC automatically
Every clearance here is in the API, with alerts when new ones post.